EMEA-000828-PIP04-16-M03
Key facts
| Invented name |
Jardiance
|
| Active substance |
empagliflozin
|
| Therapeutic area |
Endocrinology, -gynacology-fertility-metabolism
|
| Decision number |
P/0345/2019
|
| PIP number |
EMEA-000828-PIP04-16-M03
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of type I diabetes mellitus
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Boehringer Ingelheim International GmbH
Tel. +49 6132 778271 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|